Vision Pan-America (Nov 2017)

Non-Specific Orbital Inflammation and Sclerosing Variant

  • Moises Enghelberg, DO,
  • Jonathan Go, DO,
  • Adam Adika, BA,
  • Marcos Sanchez-Gonzalez, MD, PhD,
  • Dan Georgescu, MD, PhD,
  • Matthew Kay, MD

DOI
https://doi.org/10.15234/vpa.v16i4.427
Journal volume & issue
Vol. 16, no. 4
pp. 103 – 109

Abstract

Read online

This systematic review of biopsy proven cases of non specific orbital inflammation and sclerosing variant from 2010-2016 attempts to elucidate new findings regarding the demographic profile of the diseases. Discussion of histopathology is emphasized, as to describe the most common presenting features of non-specific orbital inflammation as well as to discuss its molecular make-up . This review also discusses the therapeutic approach and discusses the “steroids vs. biopsy first” controversy regarding non-specific orbital inflammation. The incidence of IgG4 and its relationship to non-specific orbital inflammation is also discussed.

Keywords